Gabelli Funds’s Neuronetics STIM Stock Holding History
Bought
Maintained
Sold
Other funds holding STIM
MAM
WC
FCM
LG
MCM
AI
IC
Gabelli Funds's STIM Position: Q2 2026 in Review
Gabelli Funds held its Neuronetics (STIM) position steady in Q2 2026 at 38,000 shares worth $49.4K. The position accounts for ﹤0.01% of the portfolio, ranked #1235.
Gabelli Funds first reported a position in STIM in Q4 2019 and has held it in 27 quarters since. The position peaked at $2.31M in Q2 2021. 86 funds tracked by Wall St. Rank hold STIM as of Q2 2026.
- Gabelli Funds held 38,000 shares of Neuronetics worth $49.4K as of Q2 2026.
- Gabelli Funds left its Neuronetics share count unchanged in Q2 2026.
- Neuronetics made up ﹤0.01% of Gabelli Funds's portfolio in Q2 2026, its #1235 holding.
- Gabelli Funds first reported a position in Neuronetics in Q4 2019 and has held it in 27 quarters since.
- Gabelli Funds's Neuronetics position peaked at $2.31M in Q2 2021.
- 86 funds tracked by Wall St. Rank held Neuronetics as of Q2 2026.
Based on Gabelli Funds's 13F filing for Q2 2026, filed 12 Aug 2026.